Recent advances in understanding the hepatotoxicity associated with protein kinase inhibitors-Reference-Cited by-同舟云学术

Recent advances in understanding the hepatotoxicity associated with protein kinase inhibitors

Published:2020-02-12 Issue:3 Volume:16 Page:217-226
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Shi Qiang¹,Yang Xi²,Ren Lijun¹,Mattes William B.¹

Affiliation:

1. Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA

2. Division of Cardiovascular and Renal Products, Office of New Drugs I, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1727886

Reference77 articles.

1. CHESS: a new human gene catalog curated from thousands of large-scale RNA sequencing experiments reveals extensive transcriptional noise

2. New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome

3. Kinase-targeted cancer therapies: progress, challenges and future directions

4. Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714

5. Causality Assessment for Suspected DILI During Clinical Phases of Drug Development

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regorafenib enhances the efficacy of photodynamic therapy in hepatocellular carcinoma through MAPK signaling pathway suppression;Photodiagnosis and Photodynamic Therapy;2024-10

2. The cyclin-dependent kinase inhibitor abemaciclib-induced hepatotoxicity: Insight on the molecular mechanisms in HepG2/THP-1 co-culture model;Toxicology Letters;2024-01

3. Liver Pathology Related to Onco-Therapeutic Agents;Surgical Pathology Clinics;2023-09

4. Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice;Drug Metabolism Reviews;2022-12-01

5. Sunitinib induced hepatotoxicity in L02 cells via ROS-MAPKs signaling pathway;Frontiers in Pharmacology;2022-10-26